Search

everythinglearnresearchcommunity

for

Search:↓

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The gene causing hair loss and heart issues in rough coat mice is still unknown.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Stopping S100A3 activity slows down hair growth in mice.

A genetic variant in the GJB6 gene likely caused the Labrador's paw pad condition.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.

Certain genes are more active during wound healing in axolotl and Acomys, which could help develop materials that improve human wound healing and regeneration.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Skin pigmentation varies due to genetics, UV exposure, and drugs, with treatments available but requiring medical advice.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Skin pigmentation varies due to genetics, UV exposure, and medications, with treatments available but requiring medical advice.

SLC45A2 and GPNMB genes help control chicken feather color by promoting melanin.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Turning off the Lhx2 gene in mouse embryos leads to slower wound healing and scars.

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Nagashima-type palmoplantar keratosis in Asians is caused by a SERPINB7 gene mutation.

Botulinum toxin Type A helps reduce hypertrophic scars and is generally safe.

Melasma is now considered a skin aging disorder caused by sun exposure in people with a genetic tendency, which impacts treatment and prevention approaches.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Human skin can make serotonin and melatonin.

Ringworm in pets is influenced by fungi type, immune status, and stress hormones.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.